HomeAI · summaries
Storia in 11 fonti
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak in Africa. The vaccine uses technology similar to the Oxford-AstraZeneca Covid-19 vaccine. This partnership aims to accelerate development and ensure access for affected nations.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
euronews.com
Health body fast-tracks three Ebola vaccines as virus continues spread
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.
- ·
koreatimes.co.kr
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...
- ·
arabnews.com
Moderna and other groups get $60m to develop Ebola vaccine
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…
- ·
channel4.com
Ebola: $62 million pledge to speed up vaccine development
A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…
- ·
arstechnica.com
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
- ·
thejakartapost.com
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
- ·
economictimes.indiatimes.com
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak…
- ·
nation.africa
Scientists target human trials for new Ebola vaccine 'within months'
This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.
- ·
businessday.ng
Race for Ebola vaccine gets $60m boost - Businessday NG
Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...
- ·
newsbytesapp.com
Serum Institute to manufacture Ebola vaccine developed by Oxford University
The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.
- ·
thehindubusinessline.com
Cepi funds three prospective vaccines targeting the epidemic-causing Ebola virus
Cepi funds three investigational vaccines for Bundibugyo ebolavirus, advancing urgent health solutions amidst a major outbreak.